Axol Bioscience

Axol Bioscience manufactures human induced pluripotent stem cell (iPSC) derived cells and provides specialized laboratory services for drug discovery and disease research. The company offers products and services across neuroscience, ophthalmology, dermatology, and cardiovascular fields, including iPSC banking, reprogramming, gene editing, and custom cell manufacturing. Their target market includes global pharmaceutical companies, contract research organizations, biotechnology firms, and academic institutions.